22 Hrs
Source:
الخليج
First patient receives pioneering cancer therapy
Britain has taken an important step in cancer treatment, as patient Tracy Tomlinson (58 years old) received the first dose of the experimental cell therapy ZI-MA4-1. This therapy is based on enhancing the immune system to target cancer cells more precisely and effectively. The treatment uses immune cells obtained from donors and combines modified NK cells with TCR receptors targeting the Mage-A4 protein found in tumors, reducing the need to design individualized treatments for each patient and lowering costs and wait times. Currently, the safety and effectiveness of this therapy are being evaluated in clinical trials involving various types of advanced cancers. This represents an unprecedented step and offers new hope for patients for whom traditional treatments no longer produce satisfactory results.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)